空間基因組學/轉錄組學市場：現況與預測（2024-2032）

Spatial Genomics & Transcriptomics Market: Current Analysis and Forecast (2024-2032)

出版日期: 2025年03月01日 | 出版商:

UnivDatos Market Insights Pvt Ltd | 英文 150 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄

預計預測期內（2024-2032 年），全球空間基因組學/轉錄組學市場規模將以 12.03% 的複合年增長率大幅增長。慢性病的流行正在推動對空間基因組學/轉錄組學等新的經濟高效的醫療保健解決方案的需求。技術進步及其與人工智慧和生物資訊學的結合正在滿足個人化醫療的需求。此外，與政府、研究機構和製藥公司的夥伴關係和協作也變得越來越普遍。透過與藥物研發公司合作，空間基因組學/轉錄組學供應商能夠提供一系列專注於細胞和組織分析的產品。例如，2022 年 1 月 5 日，Bio-Techne 和 Akoya Biosciences Inc.（為研發和臨床診斷界提供創新工具和生物活性試劑的全球生命科學公司）宣佈合作開發第一個單細胞空間多組學工作流程，用於對組織樣本進行全面、公正的分析。透過該協議，兩家公司希望向市場推出自動化空間多組學工作流程，該工作流程能夠以單細胞分辨率在整個玻片上對多種分析物進行快速原位分析。

根據技術類型，市場分為空間基因組學和空間轉錄組學。2023 年，空間基因組學市場佔據了空間基因組學/轉錄組學市場主導地位。這主要是由於精準醫療的需求不斷增長以及癌症研究的進步。客製化治療可以清晰地瞭解組織組成、細胞相互作用和基因表現。空間基因體學有助於在細胞層面上解讀癌症的複雜性。此外，這種整合將有助於組織解決空間基因組學所帶來的癌症診斷和治療日益複雜的問題，這使得研究人員能夠在基因的原生空間環境中進行研究。例如，2023 年 9 月 19 日，Akoya Biosciences, Inc. 憑藉最近推出的 PhenoCycler Fusion 2.0 和 PhenoImager HT 2.0 平台升級，強有力地展示了全幻燈片空間生物學工作流程中業界領先的規模和速度。增強型 PhenoCycler-Fusion 2.0 系統使客戶每週能夠處理兩倍的樣本，使其成為市場上吞吐量最高的空間發現平台。PhenoImager 2.0 平台可直接在 HT 儀器上進行快速即時影像分析，從而將工作流程提高了 5 倍。Akoya 的客戶將能夠加速藥物發現、臨床相關生物標記的識別以及新型空間特徵的開發，並具有前所未有的大規模執行全幻燈片空間生物學的能力。

根據產品類型，市場分為儀器、消耗品和其他。到 2023 年，家電領域將佔據較大的市場佔有率。儀器市場由大型公司主導，這些公司採用空間基因組學/轉錄組學解決方案，透過技術創新的快速進步來改善藥物發現。此外，使用人工智慧進行空間數據分析使這些工具更加實用和有吸引力。此外，這些儀器對於理解複雜的生物系統至關重要，特別是在癌症、神經科學和發育生物學等領域。因此，空間基因組學/轉錄組學與人工智慧的結合正在被大公司所採用，並為製藥公司開闢新的市場，使其擺脫對傳統技術的依賴。

根據最終用戶，市場細分為生物製藥/生物技術公司、學術和研究機構、合約研究組織等。預計生物製藥/生技公司在預測期內（2024-2032 年）將以顯著的複合年增長率成長。研究實驗室數量的快速成長、研發投入的增加以及技術的進步，為市場帶來了最大的佔有率。此外，藥物發現和開發使公司能夠識別潛在的標靶藥物並開發更有效的治療方法。這些公司正在利用空間基因組學/轉錄組學為客戶提供更好的藥物、標靶療法和精準藥物。隨著公司從政府和私人公司獲得充足的資金，對空間基因組學/轉錄組學產品的需求不斷增加，繼續推動市場發展。

本報告研究了全球空間基因組學/轉錄組學市場，並提供了有關市場動態、區域和細分分析以及公司簡介的資訊。

Spatial Genomics & Transcriptomics deals with the spatial organization of genetic and transcriptomic information within biological systems. Spatial genomics is the study of the entire DNA collection in its natural setting. It focuses on comprehending the biological processes influenced by the physical configuration of DNA within cells and tissues. By preserving the spatial linkages of the genetic material, researchers can get to know more about gene regulation, cellular connections, and structural organization of genetic material. It is vital to get to know about gene expression, genome organization, and the effect of epigenomes while maintaining the positional context. Spatial transcriptomics is the study of the transcriptome fingerprint or net gene expression of each cell during development and within diseased tissues. It may assist in providing the necessary information on cellular phenotype, cell state, and ultimately the function of the cell and tissues.

The Spatial Genomics & Transcriptomics Market is expected to grow with a significant CAGR of 12.03% during the forecast period (2024-2032). With the increasing pervasiveness of chronic diseases, there is a demand for new cost-effective, and efficient health management solutions, such as Spatial Genomics & Transcriptomics. With advancements in technology and integration with AI and Bioinformatics, it fulfills the demand for personalized medicine. Moreover, partnerships and collaborations with governments, institutions, and pharmaceutical providers are becoming increasingly common. Through partnerships with drug discoverers, Spatial Genomics & Transcriptomics suppliers can provide various products focused on cellular and tissue analysis. For instance, on January 5, 2022, Bio-Techne, a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities, and Akoya Biosciences Inc., announced a partnership to develop the first single-cell, spatial multiomics workflow for comprehensive, unbiased analysis of tissue samples. Through this agreement, the partners would bring to the market an automated, spatial multiomics workflow that can perform rapid, in situ analysis of multiple analytes, at single cell resolution, across whole slides.

Based on the technology type, the market is segmented into spatial genomics and spatial transcriptomics. The spatial genomics market dominated the spatial genomics & transcriptomics market in 2023. This is mainly due to the increased demand for precision medicine and advancements in cancer research. The tailored treatments provide explicit acumen into tissue organization, cell interactions, and gene expressions. Spatial genomics helps to decipher the complexities of cancer at the cellular level. Further, the integration assists organizations in dealing with the increasing complexities in cancer diagnosis and treatment, which is enabled by spatial genomics, as it allows researchers to study genes in their native spatial context. For instance, On Sept. 19, 2023, Akoya Biosciences, Inc. highlighted the industry-leading scale and speed in whole-slide, spatial biology workflows enabled by the recently launched PhenoCycler Fusion 2.0 and PhenoImager HT 2.0 platform upgrades. Enhancements to the PhenoCycler-Fusion 2.0 System allow customers to process twice as many samples per week, making it the highest throughput spatial discovery platform on the market. The PhenoImager 2.0 platform delivers a 5x workflow improvement by enabling rapid real-time image analysis directly on the HT instrument. With an unprecedented ability to perform whole-slide spatial biology at scale, Akoya's customers can accelerate progress towards discoveries, identification of clinically relevant biomarkers, and development of novel spatial signatures.

Based on the product type, the market is segmented into instruments, consumables, and others. The instruments segment held a significant market share in 2023. The market for instruments is led by large corporations that incorporate Spatial Genomics & Transcriptomics solutions to improve drug discoveries through rapid advancements in technological innovations. Further, the use of artificial intelligence for analyzing spatial data has enhanced the utility and appeal of these instruments. Moreover, these instruments are essential for comprehending the intricate biological systems peculiarly in areas such as cancer, neuroscience, and developmental biology. Accordingly, Spatial Genomics & Transcriptomics have gained adoption among large enterprises due to integration with AI, and it opened new markets for pharmaceutical companies breaking the dependence on traditional technologies.

Based on the end users, the market has been divided into biopharmaceutical and biotechnology companies, academic and research institutes, contract research organizations, and others. Biopharmaceutical and biotechnology companies are expected to grow with a significant CAGR in the forecast period (2024-2032). With the upsurge in the number of research laboratories, rising investments in R&D, and advancements in technology, the largest share of the market. Further, drug discoveries and development enable companies to identify potential target drug targets and develop more effective therapies. These companies utilize spatial genomics & transcriptomics to offer their clients better drugs, targeted therapies, and precision medicines. The increase in demand for spatial genomics & transcriptomics products continues to fuel the market since companies are getting ample funding from the government and private organizations.

For a better understanding of the market adoption of spatial genomics & transcriptomics market is analyzed based on its worldwide presence in countries such as North America (U.S., Canada, and the Rest of North America), Europe (Germany, France, U.K., Spain, Italy, Rest of Europe), Asia-Pacific (China, Japan, India, Rest of Asia-Pacific), Rest of World. Asia-Pacific is expected to grow with a significant CAGR in the forecast period (2024-2032). The increasing rampancy of chronic and infectious diseases, R&D investments, and the rise in the number of research laboratories in Asia-Pacific is fueling this market. Rapid economic growth and improvements in the healthcare infrastructure in the Asia Pacific countries are enabling the adoption of advanced genomic tools. Further, the partnership between international corporations and regional research institutes will help to boost regional revenue creation. Apart from this, the introduction of innovative and cost-effective sequencing platforms for academic and translational research is further driving the market. According to the Indian Council of Medical Research (ICMR) 2023, India had 163 Viral Research Diagnostic Laboratories, 117 Multidisciplinary Research Units (MRUs) and 35 Model Rural Health Research Units (MRHRUs). For instance, on October 27, 2022, Vizgen, announced the availability of its MERSCOPE(R) spatial genomics platform in Asia-Pacific (APAC), Europe, the Middle East, and Africa (EMEA). To support its global expansion, Vizgen has signed agreements with the distributors of the APAC region with Gene Company covering China/Hong Kong while PRIMETECH covers Japan.

Some of the major players operating in the market include Akoya Biosciences, Bruker Spatial Biology, Illumina, Inc., Veracyte, Inc., Macrogen, Inc., Miltenyi Biotec, Standard Biotools, Lunaphore Technologies S.A., 10x Genomics, Vizgen Inc.

1.Market Introduction

1.1. Market Definitions
1.2. Main Objective
1.3. Stakeholders
1.4. Limitation

2.Research Methodology or Assumption

2.1. Research Process of the Spatial Genomics & Transcriptomics Market
2.2. Research Methodology of the Spatial Genomics & Transcriptomics Market
2.3. Respondent Profile

3.Executive Summary

3.1. Industry Synopsis
3.2. Segmental Outlook
- 3.2.1. Market Growth Intensity
3.3. Regional Outlook

4.Market Dynamics

4.1. Drivers
4.2. Opportunity
4.3. Restraints
4.4. Trends
4.5. PESTEL Analysis
4.6. Demand Side Analysis
4.7. Supply Side Analysis
- 4.7.1. Merger & Acquisition
- 4.7.2. Investment Scenario
- 4.7.3. Industry Insights: Leading Start-ups and Their Unique Strategies

5.Pricing Analysis

5.1. Regional Pricing Analysis
5.2. Regional Pricing Analysis

6.Global Spatial Genomics & Transcriptomics Market Revenue (USD Bn), 2022-2032F

7.Market Insights By Technology Type

7.1. Spatial Genomics
7.2. Spatial Transcriptomics

8.Market Insights By Product Type

8.1. Instruments
8.2. Consumables
8.3. Others

9.Market Insights By End-Users

9.1. Biopharmaceutical and Biotechnology Companies
9.2. Academic and Research Institutes
9.3. Contract Research Organization
9.4. Others

10.Market Insights By Region

10.1. North America
- 10.1.1. U.S.
- 10.1.2. Canada
- 10.1.3. Rest of North America
10.2. Europe
- 10.2.1. Germany
- 10.2.2. France
- 10.2.3. Uk
- 10.2.4. Spain
- 10.2.5. Italy
- 10.2.6. Rest of Europe
10.3. Asia-Pacific
- 10.3.1. China
- 10.3.2. Japan
- 10.3.3. India
- 10.3.4. Rest of APAC
10.4. Rest of The World

11.Value Chain Analysis

11.1. Marginal Analysis
11.2. List of Market Participants

12.Competitive Landscape

12.1. Competition Dashboard
12.2. Competitor Market Positioning Analysis
12.3. Porter Five Forces Analysis

13.Company Profiles

13.1. Akoya Biosciences
- 13.1.1. Company Overview
- 13.1.2. Key Financials
- 13.1.3. Swot Analysis
- 13.1.4. Product Portfolio
- 13.1.5. Recent Developments
13.2. Bruker Spatial Biology
13.3. Illumina, Inc.
13.4. Veracyte, Inc.
13.5. Macrogen, Inc.
13.6. Miltenyi Biotec
13.7. Standard Biotools
13.8. Lunaphore Technologies S.A.
13.9. 10x Genomics
13.10. Vizgen Inc.